The Investigative Medicine Program (IMP) is accepting registration for Spring 2017 courses. Clinical and research faculty and fellows are invited to register through December 21 for the following courses:
IMED 655: Writing Your Career Development (K-type) Grant
Wednesdays, 1:00 PM – 3:00 PM
Dates: January 4 - May 10, 2017
Course Fee: $550
Registration Deadline: Wednesday, December 21, 2016
Withdrawal Deadline: Prior to the start of class on January 25, 2017
Course Description: In this term-long course, students will gain intensive, practical experience in evaluating and preparing grant proposals, including introduction to NIH study section format. The course gives new clinical investigators the essential tools to design and to initiate their own proposals for obtaining grants to do research and to develop their own careers. The course is limited to students who plan to submit grant proposals (for a K-type mentored career development award). Attendance and active participation are required. There may be spaces to “audit” the course. Consent of instructor required. Course Director: Eugene Shapiro, M.D. Co-Director: David Fiellin, M.D.
IMED 670: Writing Your First Independent Investigator-initiated (R-type) Grant
Wednesdays, 3:00 PM – 5:00 PM
Dates: January 4 – May 10, 2017
Course Fee: $550
Registration Deadline: Wednesday, December 21, 2016
Withdrawal Deadline: Prior to the start of class on January 25, 2017
Course Description: In this term-long course, students will gain intensive, practical experience in evaluating and preparing grant proposals, including discussion of NIH study section format. The course is particularly designed to help investigators in the "K to R” transition period. The course is limited to students who plan to submit an R-type (eg, R01 or R-21), but also VA and Foundation grant proposals. Attendance and active participation are required. There may be spaces to “audit” the course. Consent of instructor required. Course Director: Eugene Shapiro, M.D. Co-Director: David Fiellin, M.D.
IMED 680: Topics in Human Investigation
Thursdays, 3:00 PM – 4:30 PM
Dates: January 19 – May 4, 2017
Course Fee: $550
Registration Deadline: Wednesday, December 21, 2016
Withdrawal Deadline: Prior to the start of class on February 2, 2017
Course Description: The human investigation course will teach students about the process through which novel therapeutics are designed, clinically tested, and approved for human use. It is divided into two main components, with the first devoted to moving a chemical agent from the bench to the clinic, and the second to outlining the objectives and methods of conducting clinical trials to the FDA approval process. The first component will describe aspects of structure-based drug design and offer insight into how the drug discovery process is conducted in the pharmaceutical industry. The format will include background lectures with discussions, labs, and computer tutorials. Background lectures will include a historical perspective on drug discovery, the current paradigm, and important considerations for future success. The second component of the course will provide students with knowledge of the basic tools of clinical investigation and how new drugs are tested in humans. A series of lectures and discussions will provide an overview of the objectives, research strategies, and methods of conducting patient-oriented research, with a focus upon design of trials to test therapeutics. These sessions are followed by discussion of topics that are central to the conduct of clinical investigation including ethics of, and development of protocols for, human investigation. Practical experience will also be part of these latter sessions, with opportunities for students to observe the Yale Human Investigations Committee and the enrollment of patients in clinical protocols at the Hospital Research Unit. In the final lectures, clinical trials and data analysis will be discussed in the context of the FDA new drug approval process. Consent of instructor is required. Course Directors: Karen Anderson, Ph.D. and Joseph Craft, M.D.
To register, click here.